Evidence map›Paper›PMID 30883221›Full record

ArticleCirculation2019

Response by Ho et al to Letter Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".

Carolyn Y Ho, Sharlene M Day, Euan A Ashley, Michelle Michels, Alexandre C Pereira, Daniel Jacoby, Neal K Lakdawala, James S Ware, Adam S Helms, Steven D Colan and 3 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy.International journal of molecular sciences · 2023
    Review
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Carolyn Y HoCardiovascular Division, Brigham and Women's Hospital, Boston, MA (C.Y.H., N.K.L., C.E.S.).
Sharlene M DayDepartment of Internal Medicine, University of Michigan, Ann Arbor (S.M.D., A.S.H.).
Euan A AshleyStanford Center for Inherited Heart Disease, CA (E.A.A.).
Michelle MichelsDepartment of Cardiology, Thoraxcenter, Erasmus MC Rotterdam, The Netherlands (M.M.).
Alexandre C PereiraHeart Institute (InCor), University of Sao Paulo Medical School, Brazil (A.C.P.).
Daniel JacobyYale University, New Haven, CT (D.J.).
Neal K LakdawalaCardiovascular Division, Brigham and Women's Hospital, Boston, MA (C.Y.H., N.K.L., C.E.S.).
James S WareNational Heart & Lung Institute & NIHR Royal Brompton Cardiovascular Biomedical Research Unit, Imperial College London, England (J.S.W.).
Adam S HelmsDepartment of Internal Medicine, University of Michigan, Ann Arbor (S.M.D., A.S.H.).
Steven D ColanDepartment of Cardiology, Boston Children's Hospital, MA (S.D.C.).
Christine E SeidmanCardiovascular Division, Brigham and Women's Hospital, Boston, MA (C.Y.H., N.K.L., C.E.S.).
Iacopo OlivottoCardiomyopathy Unit and Genetic Unit, Careggi University Hospital, Florence, Italy (I.O.).
SHaRe Investigators

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiomyopathy, HypertrophicSarcomeresGenotypeHumansRegistries

Identifiers

PMID30883221
PMCPMC6445361

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.